How long can you take Mounjaro, and what happens when you stop?

You've been taking Mounjaro for several months and you're wondering whether there's an end date

It's a question our prescribers hear regularly, and it's a fair one. You might be approaching the highest dose, wondering whether there's a point at which you're supposed to stop, or simply anxious about whether long-term use is considered safe. The honest answer is that Mounjaro is not designed as a short course, the way antibiotics are. It works by activating two gut-hormone receptors (GIP and GLP-1) that influence appetite and the rate at which the stomach empties food. Those receptors don't permanently reset. When you stop the medicine, their action returns to baseline, and appetite typically comes back.

The SURMOUNT-1 trial, which followed around 2,500 adults over 72 weeks, found average weight reductions of roughly 20–21% at the 15 mg dose. A follow-on extension showed that participants who stopped tirzepatide regained a substantial portion of that weight within a year, even with continued lifestyle support. That pattern is consistent across the GLP-1 class, and it's why the clinical framing has shifted: for many people, this is an ongoing therapy rather than a course with a defined finish line. You can read more about how long Mounjaro is taken for weight loss and what realistic timelines look like.

None of this means you'll be on it indefinitely, your circumstances may change, your weight may stabilise, or your prescriber may judge that a supervised stop makes sense. But there is no regulatory clock ticking that forces an end at 12 or 24 months.

What the NICE guidance actually says about stopping or continuing

NICE appraised tirzepatide and published its recommendation in December 2024 (TA1026). For NHS prescribing, NICE recommends reviewing continuation if a patient loses less than 5% of their body weight after six months on the highest tolerated dose, the logic being that if the medicine isn't producing meaningful benefit, the risk-benefit calculation changes. That review trigger doesn't mean automatic discontinuation; it means a clinical conversation about whether carrying on is justified.

Crucially, NICE does not set a maximum treatment duration for tirzepatide the way it does for semaglutide under TA875, which caps NHS use at two years within a specialist service. Tirzepatide carries no equivalent time cap in its NICE recommendation or its UK licence. The NICE appraisal of tirzepatide (TA1026) is worth reading if you want the full clinical rationale in the committee's own words.

The relevant question at any review point is not 'how long have you been on it?' but 'is it still working, still tolerated, and still the right option for you?' A prescriber considers all three. Weight that has plateaued but is being maintained on treatment is still clinical benefit, weight maintenance is a legitimate goal, not a failure to progress.

What happens to your body and weight when you stop

This is where many people feel a mix of concern and resignation, and it's worth being straightforward about it. Stopping Mounjaro does not cause a unique rebound effect, your body doesn't punish you for having taken it. What does happen is that the appetite suppression fades over the weeks following your last dose, hunger signals return to their previous pattern, and without sustained changes to eating habits and activity, weight tends to creep back.

The same biology applies to stopping any effective weight-loss medicine, and it reflects how the body regulates weight rather than anything specific to tirzepatide. The NHS's patient information on tirzepatide covers this and is a good starting point for understanding what to expect. Some people use the treatment period deliberately (to establish habits, reduce weight to a point that resolves a specific condition, or improve metabolic markers) and then transition off with a plan in place. Others continue long-term. Both are valid, and neither should be decided without input from a prescriber.

If you're exploring the broader question of how long you can safely stay on Mounjaro, or wondering how quickly it begins to work before you can judge whether it's doing anything, that detail is covered in a separate piece on how long Mounjaro takes to work.

Ongoing review: what a legitimate prescribing service checks at each repeat

One thing that matters as much as duration is the quality of the clinical review each time treatment continues. A repeat supply isn't simply a refill. At every review, a prescriber should be checking that your weight trajectory remains appropriate, that side effects haven't emerged or worsened, that there are no new contraindications or medicines that interact, and that the dose is still calibrated to where you are in treatment.

Mounjaro's titration schedule starts at 2.5 mg and can move through six strengths up to 15 mg, with dose changes managed by the prescriber based on response and tolerability. A dose increase is a clinical decision, not a default next step. People with PCOS sometimes have questions about how results develop over time, and how Mounjaro affects PCOS before and after treatment is explored in a dedicated page if that applies to you. The question of cost over a longer treatment period comes up for most people eventually, a factual overview of how Mounjaro pricing works in the UK private market explains what goes into a legitimate price.

At nume, a named prescriber reads every consultation and every repeat request, the same day, and with the same rigour whether it's your first pen or your tenth. Our clinical team reviews the full picture at each stage, including any changes to your health since the previous supply, and can advise on how long you can be on Mounjaro given your individual circumstances. If you'd like to explore treatment through a clinician-led service with proper ongoing oversight, you're welcome to start your free consultation and have your eligibility assessed.